Bayer’s annual investment of 2.3 billion euros in crop science R&D powers the most productive pipeline in the industry.
Bayer recently announced pipeline project advancements and newly unveiled research in a dedicated research and development (R&D) pipeline update for the Crop Science Division. In 2019, Bayer’s pipeline delivered 55 key project and formulation advancements while providing farmers around the world with more than 450 newly commercialized hybrids and varieties of corn, soybeans, cotton and vegetables. Bayer’s annual investment of 2.3 billion euros in crop science R&D powers the most productive pipeline in the industry. With an estimated peak sales value of up to 30 billion euros, Bayer continually converts its R&D investment into innovative products that match the complexities farmers, consumers and the planet are anticipated to face.
At Bayer, we are driven to help solve some of the world’s toughest challenges. In agriculture, this means helping feed the world without starving our planet. Farmers with operations of all sizes need innovation not only to grow enough nutritious food, but also to do this in a sustainable manner that respects our planetary boundaries,” said Liam Condon, member of the Bayer Board of Management and president of the Crop Science Division. “Our employees are united around this goal, and our unrivaled pipeline is delivering against it.”
Bayer’s leadership is built on an innovation strategy that balances both incremental and disruptive approaches to R&D. With unmatched expertise across seeds and traits, crop protection and digital agriculture, Bayer invests in improving high-performing products customers already benefit from today, while also imagining new ways to farm.
